J and J Snack Foods Newswire (Page 2)

J and J Snack Foods Newswire (Page 2)

Comprehensive Real-Time News Feed for J and J Snack Foods. (Page 2)

Results 21 - 40 of 1,119 in J and J Snack Foods

  1. J&J and Bayer's Xarel to cuts recurrence of dangerous blood clots in studyRead the original story w/Photo

    Saturday Mar 18 | Channelnewsasia.com

    WASHINGTON: Longer-term use of the oral blood thinner Xarelto significantly cut the risk of recurrence of potentially life-threatening blood clots with no additional major bleeding compared with low-dose aspirin in patients at elevated risk, according to data presented on Saturday. Researchers said the results could change treatment of patients who have suffered dangerous blood clots known as venous thromboembolisms .

    Comment?

  2. articleRead the original story w/Photo

    Friday Mar 17 | Fox News

    And that growth didn't happen overnight. Since Jan. 1, 1970, Johnson & Johnson's stock has increased in value by 11,639%, through March 9, 2017.

    Comment?

  3. With tax overhaul on back burner, companies embrace M&A abroadRead the original story w/Photo

    Friday Mar 17 | WebCPA

    Intel Corp. said on Monday it is paying $15 billion to buy Israel's Mobileye NV, and in January, Johnson & Johnson agreed to buy Switzerland's Actelion Ltd. for $30 billion. In both cases, the corporations are paying for their acquisitions completely with cash they'd stashed abroad.

    Comment?

  4. Why Pacira Pharmaceuticals Stock Is Already Up 56% This YearRead the original story w/Photo

    Wednesday Mar 15 | The Motley Fool

    Exparel is helping battle back against the opioid abuse crisis. A local anesthetic, the use of Exparel during surgery can reduce pain, and decrease patients' reliance on opioids during their recovery.

    Comment?

  5. 2-part Ebola vaccine found to be effectiveRead the original story w/Photo

    Wednesday Mar 15 | CBC News

    A health care worker prepares a colleague's Ebola virus protective gear at an Ebola virus clinic operated by the International Medical Corps in Makeni, Sierra Leone, on March 2, 2015. With two vaccines showing promise, there is hope the world will be better prepared for the next Ebola outbreak.

    Comment?

  6. J & J Snack Foods Corp (JJSF) Shares Sold by Envestnet Asset Management Inc.Read the original story w/Photo

    Wednesday Mar 15 | Daily Political

    Envestnet Asset Management Inc. decreased its stake in J & J Snack Foods Corp by 1.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The fund owned 5,331 shares of the company's stock after selling 105 shares during the period.

    Comment?

  7. Autifony Therapeutics Obtains ??1.3 Million In Funding From Innovate...Read the original story

    Tuesday Mar 14 | BioSpace

    Stevenage, UK - 15 March 2017 - Autifony Therapeutics Limited , which is pioneering the development of novel pharmaceutical treatments for serious disorders of the central nervous system, today announced a new funding award of A 895,000 from the Biomedical Catalyst for initiation of a research programme with a novel approach to the treatment of dementia. An investment of A 400,000 from the Dementia Discovery Fund will also be used to pursue this highly novel approach to dementia treatment.

    Comment?

  8. Arena Pharmaceuticals' (ARNA) CEO Amit Munshi on Q4 2016 Results - Earnings Call TranscriptRead the original story w/Photo

    Tuesday Mar 14 | Seeking Alpha

    Good day everyone, and welcome to Arena Pharmaceuticals Fourth Quarter and Full-Year 2016 Financial Results and Corporate Update Conference Call. This call is being recorded.

    Comment?

  9. Two-part Ebola vaccine shows potential for long-lasting protectionRead the original story w/Photo

    Tuesday Mar 14 | The Globe and Mail

    The world should be far better prepared for the next Ebola outbreak, with further promising results on Tuesday showing the potential of a long-lasting vaccine against the deadly virus. The two-part shot from Johnson & Johnson and Danish partner Bavarian Nordic induced a durable immune response lasting a full year in 100 per cent of healthy volunteers vaccinated, researchers reported.

    Comment?

  10. St. Louis Court rules in Favor of J&J in Talc Ovarian Cancer LawsuitRead the original story w/Photo

    Wednesday Mar 8 | US Recall News

    On March 3, 2017, a Missouri jury ruled in favor of Johnson & Johnson and its talc supplier Imerys Talc in a lawsuit by a woman who alleged that J&J talcum powder products for feminine hygiene for 36 years caused her ovarian cancer. The victory for J&J comes after three consecutive losses in the St. Louis court, in which juries awarded a combined total of 55 year-old Nora Daniels, of Tennessee, was diagnosed with ovarian and uterine cancer in 2013.

    Comment?

  11. France's Top Body Wash Looks to Make It Big in U.S.Read the original story w/Photo

    Tuesday Mar 14 | Advertising Age

    Register to become a member today. You'll get the essential information you need to do your job better, including The news and features are funded in part by our advertisers.

    Comment?

  12. RPT-Two-part Ebola vaccine offers long-lasting protectionRead the original story w/Photo

    Tuesday Mar 14 | Reuters

    The world should be far better prepared for the next Ebola outbreak, with further promising results on Tuesday showing the potential of a long-lasting vaccine against the deadly virus. The two-part shot from Johnson & Johnson and Danish partner Bavarian Nordic induced a durable immune response lasting a full year in 100 percent of healthy volunteers vaccinated, researchers reported.

    Comment?

  13. Two-part Ebola vaccine offers long-lasting protectionRead the original story w/Photo

    Tuesday Mar 14 | Reuters

    The world should be far better prepared for the next Ebola outbreak, with further promising results on Tuesday showing the potential of a long-lasting vaccine against the deadly virus. The two-part shot from Johnson & Johnson and Danish partner Bavarian Nordic induced a durable immune response lasting a full year in 100 percent of healthy volunteers vaccinated, researchers reported.

    Comment?

  14. Brokerages Set $127.50 Target Price for J & J Snack Foods CorpRead the original story w/Photo

    Tuesday Mar 14 | IntersportsWire

    J & J Snack Foods Corp has earned an average broker rating score of 2.50 from the four analysts that provide coverage for the stock, Zacks Investment Research reports. Three analysts have rated the stock with a hold recommendation and one has assigned a strong buy recommendation to the company.

    Comment?

  15. Comerica Bank Purchases 891 Shares of J & J Snack Foods CorpRead the original story w/Photo

    Tuesday Mar 14 | IntersportsWire

    Comerica Bank boosted its position in J & J Snack Foods Corp by 5.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The firm owned 16,202 shares of the company's stock after buying an additional 891 shares during the period.

    Comment?

  16. J & J Snack Foods Corp (JJSF) Shares Bought by Dimensional Fund Advisors LPRead the original story w/Photo

    Monday Mar 13 | IntersportsWire

    Dimensional Fund Advisors LP increased its stake in J & J Snack Foods Corp by 1.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 439,146 shares of the company's stock after buying an additional 4,838 shares during the period.

    Comment?

  17. Intel to buy driverless tech firm Mobileye for $15.3bnRead the original story w/Photo

    Monday Mar 13 | Financial Times

    Intel, the US chipmaker, will pay more than $15bn to buy Mobileye, the maker of autonomous driving technology, in an attempt to take a leading position in the self-driving car market. In Israel's biggest-ever corporate acquisition, Intel said it would buy New York-listed Mobileye's shares for $63.54 each in cash, representing an equity value of some $15.3bn and an enterprise value of $14.7bn.

    Comment?

  18. The 3 Most Important Numbers For Johnson & JohnsonRead the original story

    Sunday Mar 12 | BioSpace

    Your eyes would probably gloss over looking at all of the figures Johnson & Johnson puts up. From adjusted earnings to Zyrtec sales, the healthcare giant generates a massive volume of statistics in managing its global operations.

    Comment?

  19. Global Surgical Stapling Devices Market 2016: Manufacturers, Regions, Type and Application, ForecastRead the original story w/Photo

    Thursday Mar 9 | SBWire

    Latest industry research report on: Global Surgical Stapling Devices Market 2016: Industry Research, Size, Shares, Key Trends, Demand, Analysis, Performance, Growth, Segmentation, Parameters, Consumption and Prospects to 2021 Surgical Stapling Device is medical device which is used to place surgical staples. Surgical staples are specialized staples used in surgery in place of sutures to close skin wounds, connect or remove parts of the bowels or lungs.

    Comment?

  20. Opioid API firm Noramco moves into cannabinoidsRead the original story w/Photo

    Wednesday Mar 8 | In-PharmaTechnologist.com

    The US opioid-based active pharmaceutical ingredient announced its intention to reshape its businesses this week, explaining that it has started supplying cannabinoids in response to growing drug industry demand. The former J&J unit told us " after recently adding the full line of mixed amphetamines to our product list Noramco is adding Cannabidiol for Clinical and Pharmaceutical use to our product portfolio .

    Comment?